Tong Ren Tang Technologies Co (HKSE:01666) Debt-to-Equity : 0.34 (As of Jun. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Tong Ren Tang Technologies Co Debt-to-Equity?

Tong Ren Tang Technologies Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was HK$618 Mil. Tong Ren Tang Technologies Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was HK$1,979 Mil. Tong Ren Tang Technologies Co's Total Stockholders Equity for the quarter that ended in Jun. 2024 was HK$7,639 Mil. Tong Ren Tang Technologies Co's debt to equity for the quarter that ended in Jun. 2024 was 0.34.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Tong Ren Tang Technologies Co's Debt-to-Equity or its related term are showing as below:

HKSE:01666' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.03 Med: 0.25 Max: 0.43
Current: 0.34

During the past 13 years, the highest Debt-to-Equity Ratio of Tong Ren Tang Technologies Co was 0.43. The lowest was 0.03. And the median was 0.25.

HKSE:01666's Debt-to-Equity is ranked worse than
55.99% of 827 companies
in the Drug Manufacturers industry
Industry Median: 0.28 vs HKSE:01666: 0.34

Tong Ren Tang Technologies Co Debt-to-Equity Historical Data

The historical data trend for Tong Ren Tang Technologies Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tong Ren Tang Technologies Co Debt-to-Equity Chart

Tong Ren Tang Technologies Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.27

0.29

0.28

0.25

0.24

Tong Ren Tang Technologies Co Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Debt-to-Equity	Get a 7-Day Free Trial															0.27	0.25	0.25	0.24	0.34

Competitive Comparison of Tong Ren Tang Technologies Co's Debt-to-Equity

For the Drug Manufacturers - General subindustry, Tong Ren Tang Technologies Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tong Ren Tang Technologies Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tong Ren Tang Technologies Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Tong Ren Tang Technologies Co's Debt-to-Equity falls into.

Tong Ren Tang Technologies Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Tong Ren Tang Technologies Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(165.511	+	1614.302)	/	7535.499
	=	0.24

Tong Ren Tang Technologies Co's Debt to Equity Ratio for the quarter that ended in Jun. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(618.375	+	1979.226)	/	7638.767
	=	0.34

Tong Ren Tang Technologies Co (HKSE:01666) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Tong Ren Tang Technologies Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Tong Ren Tang Technologies Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Tong Ren Tang Technologies Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tong Ren Tang Technologies Co Ltd (HKSE:01666) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

TGRNF:USA

Address

No. 16 Tongji Beilu, Beijing Economic and Technological Development Zone, Beijing, CHN

Website

https://www.tongrentangkj.com

Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and predominantly operates in Mainland China and Hong Kong. The operating segments derive their revenue predominantly from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.

Executives

Citigroup Inc.	2502 Approved lending agent
Hillhouse Capital Advisors, Ltd.	2102 Investment manager
Aberdeen Asset Management Plc And Its Associates	2102 Investment manager

Tong Ren Tang Technologies Co Headlines

No Headlines